These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort. Lazenby GB; Hill A; Tarleton J; Soper D Sex Transm Dis; 2020 May; 47(5):332-337. PubMed ID: 32149959 [TBL] [Abstract][Full Text] [Related]
24. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348 [TBL] [Abstract][Full Text] [Related]
25. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852 [TBL] [Abstract][Full Text] [Related]
26. Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic. Muzny CA; Burkholder GA; Fry KR; Austin EL; Schwebke JR Sex Transm Dis; 2016 Aug; 43(8):483-8. PubMed ID: 27419815 [TBL] [Abstract][Full Text] [Related]
27. United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014. Sherrard J; Ison C; Moody J; Wainwright E; Wilson J; Sullivan A Int J STD AIDS; 2014 Jul; 25(8):541-9. PubMed ID: 24616117 [TBL] [Abstract][Full Text] [Related]
28. The prevalence and risk factors for Ijasan O; Okunade KS; Oluwole AA Niger Postgrad Med J; 2018; 25(1):21-26. PubMed ID: 29676341 [TBL] [Abstract][Full Text] [Related]
29. Aptima Bruni MP; Freitas da Silveira M; Stauffert D; Bicca GLO; Caetano Dos Santos C; da Rosa Farias NA; Golparian D; Unemo M Sex Transm Infect; 2019 Mar; 95(2):129-132. PubMed ID: 30154157 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of Conventional Methods with Molecular Methods in the Diagnosis of Trichomonas vaginalis and Investigation of Metronidazole Resistance]. Özel Y; Çavuş İ; Usta A; Vardar Ünlü G; Özbilgin A; Ünlü M Mikrobiyol Bul; 2023 Oct; 57(4):625-638. PubMed ID: 37885390 [TBL] [Abstract][Full Text] [Related]
32. The Association Between Human Immunodeficiency Virus and Bacterial Vaginosis and Metronidazole Treatment Failure for Trichomonas vaginalis. Frechtling D; Chopra S; Ratnayake A; Kissinger PJ Sex Transm Dis; 2024 Jan; 51(1):61-64. PubMed ID: 37921835 [TBL] [Abstract][Full Text] [Related]
33. Factors associated with Trichomonas vaginalis infection in reproductive-aged women attending cervical screening in southeast of Brazil. da Silva Pinto GV; Bolpet ADN; Martin LF; Moço NP; Ramos BRA; Silva MC; Duarte MTC; da Rocha Tristão A; da Silva MG; Marconi C Braz J Infect Dis; 2023; 27(4):102794. PubMed ID: 37500061 [TBL] [Abstract][Full Text] [Related]
34. Trichomonas vaginalis Virus Among Women With Trichomoniasis and Associations With Demographics, Clinical Outcomes, and Metronidazole Resistance. Graves KJ; Ghosh AP; Schmidt N; Augostini P; Secor WE; Schwebke JR; Martin DH; Kissinger PJ; Muzny CA Clin Infect Dis; 2019 Nov; 69(12):2170-2176. PubMed ID: 30768180 [TBL] [Abstract][Full Text] [Related]
35. Dealing with trichomoniasis. Young F J Fam Health Care; 2006; 16(5):153-5. PubMed ID: 17139977 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of amixicile against T. vaginalis from clinical isolates. Jain E; Zaenker EI; Hoffman PS; Warren CA Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563 [TBL] [Abstract][Full Text] [Related]
37. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy. Forbes GL; Drayton R; Forbes GD Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945 [TBL] [Abstract][Full Text] [Related]
38. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial. Kissinger P; Muzny CA; Mena LA; Lillis RA; Schwebke JR; Beauchamps L; Taylor SN; Schmidt N; Myers L; Augostini P; Secor WE; Bradic M; Carlton JM; Martin DH Lancet Infect Dis; 2018 Nov; 18(11):1251-1259. PubMed ID: 30297322 [TBL] [Abstract][Full Text] [Related]
39. Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community. Munson E; Napierala M; Schell RF Expert Rev Anti Infect Ther; 2013 Aug; 11(8):845-63. PubMed ID: 23944153 [TBL] [Abstract][Full Text] [Related]
40. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations. Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]